ImmuCell Corporation Payments of Debt Issuance Costs
ImmuCell Corporation (ICCC) reported Payments of Debt Issuance Costs of $14.63 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-03-30
- ImmuCell Corporation payments of debt issuance costs for the quarter ending 2025-12-31 was $0.00.
- ImmuCell Corporation payments of debt issuance costs for the quarter ending 2024-12-31 was $0.00.
- ImmuCell Corporation payments of debt issuance costs for the quarter ending 2024-09-30 was $0.00.
- ImmuCell Corporation payments of debt issuance costs for the quarter ending 2024-06-30 was $0.00.
- ImmuCell Corporation payments of debt issuance costs for fiscal 2025 was $14.63K, a 190.51% increase from fiscal 2024.
- ImmuCell Corporation payments of debt issuance costs for fiscal 2024 was $5.04K, a 85.78% decline from fiscal 2023.
- ImmuCell Corporation payments of debt issuance costs for fiscal 2023 was $35.42K, a 83.49% increase from fiscal 2022.
- ImmuCell Corporation payments of debt issuance costs for fiscal 2022 was $19.31K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 9 month as first filed | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $14.63K 10-K · filed 2026-03-30 | |||
| 2025-09-30 | $14.63K 10-Q · filed 2025-11-13 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-03-30 | $5.04K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $5.04K 10-Q · filed 2025-11-13 | -$57.64K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $5.04K 10-Q · filed 2025-08-14 | -$57.64K derived: sum of 3 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $5.04K 10-Q · filed 2025-05-14 | -$57.64K derived: sum of 2 quarters · filed 2025-05-14 | |||
| 2023-12-31 | -$62.67K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $35.42K 10-K · filed 2025-03-28 | |||
| 2023-09-30 | $98.10K 10-Q · filed 2024-11-13 | $35.42K 10-Q · filed 2023-11-13 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $19.31K 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $19.31K 10-Q · filed 2023-11-13 | ||||
| 2020-12-31 | $13.35K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $13.35K derived: sum of 2 quarters · filed 2021-03-30 | $13.35K derived: sum of 3 quarters · filed 2021-03-30 | $53.14K 10-K · filed 2021-03-30 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $39.79K 10-Q · filed 2020-11-12 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $39.79K 10-Q · filed 2020-08-12 | |||
| 2020-03-31 | $39.79K 10-Q · filed 2020-05-13 | ||||
| 2018-12-31 | $1.45K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $1.45K derived: sum of 2 quarters · filed 2020-03-27 | $1.45K derived: sum of 3 quarters · filed 2020-03-27 | $1.97K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $522.00 10-Q · filed 2019-11-12 | $3.27K derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $522.00 10-Q · filed 2019-08-12 | $3.27K derived: sum of 3 quarters · filed 2019-08-12 | $4.31K derived: sum of 4 quarters · filed 2019-08-12 | |
| 2018-03-31 | $522.00 10-Q · filed 2019-05-13 | $3.27K derived: sum of 2 quarters · filed 2019-05-13 | $4.31K derived: sum of 3 quarters · filed 2019-05-13 | $12.59K derived: sum of 4 quarters · filed 2019-05-13 | |
| 2017-12-31 | $2.74K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $3.79K derived: sum of 2 quarters · filed 2019-03-22 | $12.06K derived: sum of 3 quarters · filed 2019-03-22 | $66.10K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $1.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $9.32K derived: sum of 2 quarters · filed 2018-11-13 | $63.36K 10-Q · filed 2018-11-13 | $63.36K derived: sum of 4 quarters · filed 2018-11-13 | |
| 2017-06-30 | $8.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $62.31K 10-Q · filed 2018-08-13 | $62.31K derived: sum of 3 quarters · filed 2018-08-13 | $62.31K derived: sum of 4 quarters · filed 2018-08-13 | |
| 2017-03-31 | $54.04K 10-Q · filed 2018-05-14 | $54.04K derived: sum of 2 quarters · filed 2018-05-14 | $54.04K derived: sum of 3 quarters · filed 2018-05-14 | $63.88K derived: sum of 4 quarters · filed 2018-05-14 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $0.00 derived: sum of 2 quarters · filed 2018-03-29 | $9.84K derived: sum of 3 quarters · filed 2018-03-29 | $46.73K 10-K · filed 2018-03-29 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $9.84K derived: sum of 2 quarters · filed 2017-11-13 | $46.73K 10-Q · filed 2017-11-13 | $48.10K derived: sum of 4 quarters · filed 2017-11-13 | |
| 2016-06-30 | $9.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $46.73K 10-Q · filed 2017-08-14 | $48.10K derived: sum of 3 quarters · filed 2017-08-14 | $82.22K derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | $36.89K 10-Q · filed 2017-05-11 | $38.26K derived: sum of 2 quarters · filed 2017-05-11 | $72.38K derived: sum of 3 quarters · filed 2017-05-11 | $72.38K derived: sum of 4 quarters · filed 2017-05-11 | |
| 2015-12-31 | $1.37K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $35.49K derived: sum of 2 quarters · filed 2017-03-30 | $35.49K derived: sum of 3 quarters · filed 2017-03-30 | $34.13K 10-K · filed 2017-03-30 | |
| 2015-09-30 | $34.13K 10-K · filed 2017-03-30 | $34.13K derived: sum of 2 quarters · filed 2017-03-30 | $32.76K 10-Q · filed 2016-11-10 | $34.13K derived: sum of 4 quarters · filed 2017-03-30 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $0.00 10-Q · filed 2016-08-11 | $0.00 derived: sum of 3 quarters · filed 2016-08-11 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-11 | $0.00 derived: sum of 2 quarters · filed 2016-05-11 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $0.00 10-K · filed 2016-03-25 | |||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-12 | ||||
| 2013-12-31 | $0.00 10-K · filed 2016-03-25 | ||||
| 2010-09-30 | $26.49K 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |